The cost of pretomanid, a crucial tuberculosis drug, has fallen by 25% to under $1 per day as of April. The price reduction follows the launch of a new formulation by Lupin, a Mumbai-based manufacturer. 

Lupin is one of five companies licensed by the non-profit TB Alliance to produce pretomanid, fostering competition to drive prices down and ensure market access.

To speak to us about this, we are joined on the line by Dr. Mel Spigelman, President and CEO of TB Alliance.

The cost of pretomanid, a crucial tuberculosis drug, has fallen by 25% to under $1 per day as of April. The price reduction follows the launch of a new formulation by Lupin, a Mumbai-based manufacturer.&nbsp;
Lupin is one of five companies licensed by the non-profit TB Alliance to produce pretomanid, fostering competition to drive prices down and ensure market access.
To speak to us about this, we are joined on the line by Dr. Mel Spigelman, President and CEO of TB Alliance.

Fast-paced news and current affairs updates, dealing with topical issues & breaking stories.

Fast-paced news and current affairs updates, dealing with topical issues &amp; breaking stories.